Dr. Raquel Lashawn Rhone is a pharmacist who is specialized in Oncology in Dallas, Texas. Patients can reach her at 3535 Worth St Ste 170, Dallas or contact her on 214-370-1612. Active license number of Dr. Raquel Lashawn Rhone is 35559 for Oncology in Texas. Dr. Raquel Lashawn Rhone is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Raquel Lashawn Rhone speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Raquel Lashawn Rhone
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
3535 Worth St Ste 170, Dallas, Texas, 75246-2006
Phone:
214-370-1612
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Raquel Lashawn Rhone are as mentioned below.
NPI Number:
1356411714
NPI Enumeration Date:
09 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Raquel Lashawn Rhone are as mentioned below.
Specialization
License Number
State
Status
Oncology
35559
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1833 Cedarbriar Dr, Mesquite, Texas
Zip:
75181-2430
Phone Number:
972-222-2805
Fax Number:
--
Patients can reach Dr. Raquel Lashawn Rhone at 3535 Worth St Ste 170, Dallas, Texas or can call on phone at 214-370-1612.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.